acetylphenylalanyl-prolyl-boroarginine has been researched along with rs-130830 in 1 studies
| Studies (acetylphenylalanyl-prolyl-boroarginine) | Trials (acetylphenylalanyl-prolyl-boroarginine) | Recent Studies (post-2010) (acetylphenylalanyl-prolyl-boroarginine) | Studies (rs-130830) | Trials (rs-130830) | Recent Studies (post-2010) (rs-130830) |
|---|---|---|---|---|---|
| 30 | 0 | 0 | 19 | 0 | 8 |
| Protein | Taxonomy | acetylphenylalanyl-prolyl-boroarginine (IC50) | rs-130830 (IC50) |
|---|---|---|---|
| Collagenase 3 | Bos taurus (cattle) | 0.004 | |
| Interstitial collagenase | Homo sapiens (human) | 0.2062 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.0001 | |
| Stromelysin-1 | Homo sapiens (human) | 0.0533 | |
| Matrilysin | Homo sapiens (human) | 0.9325 | |
| Stromelysin-2 | Homo sapiens (human) | 0.0005 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.0463 | |
| Neutrophil collagenase | Homo sapiens (human) | 0.0001 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.014 | |
| Collagenase 3 | Homo sapiens (human) | 0.0367 | |
| Matrix metalloproteinase-14 | Homo sapiens (human) | 0.0043 | |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | 0.1316 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.014 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
1 review(s) available for acetylphenylalanyl-prolyl-boroarginine and rs-130830
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |